GB Patent
GB8403138D0 — Sustained release of active ingredient
Assigned to Huehns E R · Expires 1984-03-14 · 42y expired
What this patent protects
Patent listed against Gemzar.
Drugs covered by this patent
- Gemzar (Gemcitabine Hydrochloride) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.